Dear editor,
Hepcidin, an iron metabolism regulatory peptide has been proposed as a risk factor for atherosclerosis, 1 and there is recent evidence supporting this possibility. 2 Low hepcidin production combined with increased ferroportin synthesis strongly favors release of iron from reticuloendothelial storage sites and thus supports a shift of endogenous iron from storage to new red blood cell hemoglobin. Oxidative stress plays an important role in neuronal injuries caused by cerebral ischemia. It is known that free iron increases significantly during ischemia and is responsible for oxidative damage in the brain. Many mechanisms are involved in ischemia-induced brain injuries, such as oxidative stress, 3 increased intracellular calcium concentration, 4 inflammation, 5 and elevated excitatory amino acids. 6 Increased levels of free iron and ferritin have been observed in ischemic brain. 7 Elevated hypoxia inducible factor 1 (HIF-1) expression causes high secretion of hepcidin. 8 Samples were taken from 74 patients with ischemic stroke, diagnosed in ''Aleksandrovska'' hospital, Dept. of Neurology; average age 54.1 AE 4.9. Their results were compared to 74 age matched controls. We measure serum iron levels, ferritin and IL-6. Pearson's coefficient and Student's t-test were used for evaluation of correlation and statistical significance. We quantify hepcidin levels using verified ELISA method. 9 For iron quantification we used AAS (Perkin Elmer) and for serum ferritin levels -CLIA method (Siemens Healthcare). IL-6 was measured by ELISA method. Patients were signing the informed consent according to the Declaration of Helsinki (Directive 2001/ 20/EC).
We found significant elevated serum hepcidin levels in patients with acute ischemic stroke 97.6 AE 12.4 mg/L compared to the control group 22.7 AE 5.1 mg/L (p < 0.001) (Figure 1 ). Serum IL-6 levels showed significant differences between the groups: control group: 3.4 AE 1.2 ng/L to patients with ischemic stroke 21.9 AE 2.8 ng/L (p < 0.001) ( Figure 2 ). Serum hepcidin levels were established in the previous study. 10 Serum iron levels were increased in patients with ischemic stroke: 41.1 AE 4.2 mmol/L to 22.9 AE 5.1 mmol/L (p < 0.001).
We found a significant correlation between serum iron levels and hepcidin concentration in both groups: patients with ischemic stroke (r ¼ 0.620, p < 0.001) and in control group (r ¼ 0.423, p < 0.001).
It is known that inflammation up-regulates hepcidin expression and that cytokines are a major mediator of the inflammatory response. HIF-1 is one of the factors activated in early ischemia that can induce vascular endothelial growth factor, erythropoietin, etc. 11 Previous studies have shown that iron chelators, can reduce injury caused by cardiac ischemia and reperfusion 12 and cerebral ischemia. 13 In our study we found high serum hepcidin levels, elevated IL-6, iron and ferritin concentrations in patients with ischemic stroke.
Recently, there are two pathways that contribute to iron overload in ischemic brain tissues as outlined. A) Ischemia increases the expression of cytokines that up-regulates hepcidin by the JAK/STAT3 pathway, which causes iron accumulation. And B) Ischemia upregulates the HIF-1a level, which leads to iron accumulation in the ischemic tissues.
Our results indicate that serum hepcidin plays an important role for iron overload in cerebral ischemia.
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